22,400 Shares in Edap Tms S.A. (NASDAQ:EDAP) Bought by Illumine Investment Management LLC

Illumine Investment Management LLC acquired a new stake in Edap Tms S.A. (NASDAQ:EDAP) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 22,400 shares of the medical equipment provider’s stock, valued at approximately $50,000. Illumine Investment Management LLC owned about 0.06% of Edap Tms at the end of the most recent reporting period.

A number of other large investors have also recently modified their holdings of the business. BNP Paribas Financial Markets lifted its stake in Edap Tms by 23.7% in the 3rd quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock valued at $59,000 after purchasing an additional 4,400 shares during the last quarter. Orion Capital Management LLC grew its position in Edap Tms by 10.4% during the 3rd quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider’s stock worth $178,000 after acquiring an additional 6,600 shares during the last quarter. Finally, Parkman Healthcare Partners LLC acquired a new position in Edap Tms in the 3rd quarter worth about $395,000. Institutional investors and hedge funds own 62.74% of the company’s stock.

Edap Tms Stock Performance

NASDAQ EDAP opened at $2.61 on Friday. The company has a market capitalization of $96.84 million, a price-to-earnings ratio of -4.02 and a beta of 0.36. The company has a quick ratio of 1.46, a current ratio of 2.18 and a debt-to-equity ratio of 0.08. Edap Tms S.A. has a twelve month low of $2.00 and a twelve month high of $8.50. The stock has a fifty day simple moving average of $2.38 and a 200 day simple moving average of $2.70.

Wall Street Analyst Weigh In

Separately, StockNews.com initiated coverage on Edap Tms in a report on Monday. They set a “hold” rating on the stock.

Edap Tms Profile

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.